{"description":"Scientific Opinion on the substantiation of a health claim related to OPC Premium and the reduction of blood cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006 23 October 2009 http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902971744.htm 1\u30ab\u30d7\u30bb\u30eb\u3042\u305f\u308a40mg\u306e\u30d7\u30ed\u30b7\u30a2\u30cb\u30b8\u30f3\u30aa\u30ea\u30b4\u30de\u30fc\uff08OPC\uff09\u306840\u2026","title":"OPC Premium \u3068\u8840\u4e2d\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u524a\u6e1b\u306b\u95a2\u3059\u308b\u5065\u5eb7\u5f37\u8abf\u8868\u793a\u306e\u7acb\u8a3c\u306b\u95a2\u3059\u308b\u79d1\u5b66\u7684\u610f\u898b","height":"190","author_name":"uneyama","categories":["EFSA"],"image_url":null,"author_url":"https://blog.hatena.ne.jp/uneyama/","url":"https://uneyama.hatenadiary.jp/entry/20091026/p3","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20091026%2Fp3\" title=\"OPC Premium \u3068\u8840\u4e2d\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u524a\u6e1b\u306b\u95a2\u3059\u308b\u5065\u5eb7\u5f37\u8abf\u8868\u793a\u306e\u7acb\u8a3c\u306b\u95a2\u3059\u308b\u79d1\u5b66\u7684\u610f\u898b - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","type":"rich","version":"1.0","blog_url":"https://uneyama.hatenadiary.jp/","width":"100%","provider_name":"Hatena Blog","published":"2009-10-26 00:00:02","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","provider_url":"https://hatena.blog"}